{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:59:07Z","timestamp":1793948347084,"version":"4.8.0"},"reference-count":69,"publisher":"IOP Publishing","issue":"5","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"}],"funder":[{"name":"The \u201cPioneer\u201d and \u201cLeading Goose\u201d R&D Program of Zhejiang","award":["2024C03107"],"award-info":[{"award-number":["2024C03107"]}]},{"name":"Joint TCM Science & Technology Projects of National Demonstration Zones for Comprehensive TCM Reform","award":["GZY-KJS-ZJ-2025-081"],"award-info":[{"award-number":["GZY-KJS-ZJ-2025-081"]}]},{"name":"Zhejiang Province Traditional Chinese medicine science and technology project","award":["2024ZL857"],"award-info":[{"award-number":["2024ZL857"]}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Nanotechnology"],"published-print":{"date-parts":[[2026,2,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Immunosuppression within the tumor microenvironment (TME) is a major factor driving pancreatic cancer progression and therapeutic resistance. To address this challenge, we developed a nano-codelivery system, CGT (Cilengitide)-Cls-PTX (paclitaxel)\/CM (cell membrane), for the co-delivery of PTX and tumor cell lysate-derived antigens from pancreatic cancer cells (from human pancreatic cancer PANC-1 and mouse pancreatic cancer PANC02 cells). The system was constructed by synthesizing an integrin\n                    <jats:italic>\u03b1<\/jats:italic>\n                    v\n                    <jats:italic>\u03b2<\/jats:italic>\n                    3-targeting lipid, DSPE-PEG\n                    <jats:sub>2000<\/jats:sub>\n                    -CGT, and fusing PTX-loaded liposomes with pancreatic cancer cell membranes. This strategy enables preferential accumulation in the TME, where tumor antigens are released to stimulate dendritic cell (DC) maturation and relieve TME immunosuppression, thereby achieving synergistic antitumor efficacy via PTX-mediated tumor cell killing and antigen-induced immune activation. Physicochemical characterization by\n                    <jats:sup>1<\/jats:sup>\n                    H-nuclear magnetic resonance, transmission electron microscopy, and Western blot confirmed successful synthesis and membrane fusion. Immunostimulatory activity was evaluated using ELISA, flow cytometry, and co-culture assays, and therapeutic efficacy was assessed in a PANC02 murine pancreatic cancer model with Cls-PTX as the control. CGT-Cls-PTX\/CM significantly enhanced DC maturation, upregulated co-stimulatory molecules (CD80, CD86), and promoted secretion of interleukin-6 (IL-6) and interleukin-12 (IL-12). Furthermore, it increased CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell proliferation, elevated interferon-\n                    <jats:italic>\u03b3<\/jats:italic>\n                    (IFN-\n                    <jats:italic>\u03b3<\/jats:italic>\n                    ) production, suppressed transforming growth factor-\n                    <jats:italic>\u03b2<\/jats:italic>\n                    , and facilitated cytotoxic T lymphocyte infiltration into tumor tissues. Overall, CGT-Cls-PTX\/CM effectively remodels the immunosuppressive TME, achieving synergistic antitumor effects through combined chemotherapy and immune modulation. This strategy offers a promising approach for enhancing immunotherapeutic efficacy against pancreatic ductal adenocarcinoma, a prototypical \u2018cold\u2019 tumor resistant to immune checkpoint therapy.\n                  <\/jats:p>","DOI":"10.1088\/1361-6528\/ae39e3","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T22:47:53Z","timestamp":1768862873000},"page":"055101","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Construction and synergistic effect of a CGT-Cls-PTX\/CM nanocodelivery system targeting the tumor microenvironment"],"prefix":"10.1088","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7590-5373","authenticated-orcid":true,"given":"Yun","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"266","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"nanoae39e3bib1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jare.2024.01.014","type":"journal-article","article-title":"The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer","volume":"67","author":"Tang","year":"2024","journal-title":"J. Adv. Res."},{"key":"nanoae39e3bib2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","type":"journal-article","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA"},{"key":"nanoae39e3bib3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.21873\/anticanres.16919","type":"journal-article","article-title":"A retrospective study of gemcitabine plus nab-paclitaxel for advanced pancreatic cancer refractory to gemcitabine monotherapy","volume":"44","author":"Mariko","year":"2024","journal-title":"Anticancer Res."},{"key":"nanoae39e3bib4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.canlet.2013.09.039","type":"journal-article","article-title":"The stromal compartments in pancreatic cancer: are there any therapeutic targets?","volume":"343","author":"Lunardi","year":"2014","journal-title":"Cancer Lett."},{"key":"nanoae39e3bib5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10555-021-09981-3","type":"journal-article","article-title":"Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance","volume":"40","author":"Heumann","year":"2021","journal-title":"Cancer Metastasis Rev."},{"key":"nanoae39e3bib6","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.12998\/wjcc.v9.i13.2969","type":"journal-article","article-title":"Immunotherapy for pancreatic cancer","volume":"9","author":"Yoon","year":"2021","journal-title":"World J. Clin. Case"},{"key":"nanoae39e3bib7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109821","type":"journal-article","article-title":"Cancer immunotherapy: pros, cons and beyond","volume":"124","author":"Shuzhen","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"nanoae39e3bib8","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1021\/acs.accounts.0c00334","type":"journal-article","article-title":"Recent advances in stimuli-responsive platforms for cancer immunotherapy","volume":"53","author":"Li","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"nanoae39e3bib9","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2174\/0118715303169428231205173914","type":"journal-article","article-title":"In silico identification of MHC displayed tumor associated peptides in ovarian cancer for multi-epitope vaccine construct","volume":"24","author":"Dobhal","year":"2024","journal-title":"Endocr. Metab. Immune Disord."},{"key":"nanoae39e3bib10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","type":"journal-article","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Robert","year":"2021","journal-title":"Blood Cancer J."},{"key":"nanoae39e3bib11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","type":"journal-article","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"nanoae39e3bib12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biomaterials.2017.01.017","type":"journal-article","article-title":"A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy","volume":"122","author":"Fei","year":"2017","journal-title":"Biomaterials"},{"key":"nanoae39e3bib13","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.2174\/0113816128265544231102065515","type":"journal-article","article-title":"Antibody-modified gold nanobiostructures: advancing targeted photodynamic therapy for improved cancer treatment","volume":"29","author":"Negin","year":"2023","journal-title":"Curr. Pharm. Des."},{"key":"nanoae39e3bib14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12553","type":"journal-article","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Qian","year":"2016","journal-title":"Nat. Commun."},{"key":"nanoae39e3bib15","doi-asserted-by":"publisher","first-page":"e6800","DOI":"10.1002\/cam4.6800","type":"journal-article","article-title":"RGD peptide in cancer targeting: benefits, challenges, solutions, and possible integrin-RGD interactions","volume":"13","author":"Hossein","year":"2024","journal-title":"Cancer Med."},{"key":"nanoae39e3bib16","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1158\/1535-7163.MCT-17-1090","type":"journal-article","article-title":"iRGD-guided tumor-penetrating nanocomplexes for therapeutic siRNA delivery to pancreatic cancer","volume":"17","author":"Justin","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"nanoae39e3bib17","doi-asserted-by":"publisher","DOI":"10.1049\/nbt2\/4959295","type":"journal-article","article-title":"Nanocodelivery of 5-fluorouracil and curcumin by RGD-decorated nanoliposomes achieves synergistic chemotherapy for breast cancer","volume":"2024","author":"Reza","year":"2024","journal-title":"IET Nanobiotechnol."},{"key":"nanoae39e3bib18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jconrel.2016.01.015","type":"journal-article","article-title":"Glioma-targeted therapy using Cilengitide nanoparticles combined with UTMD enhanced delivery","volume":"224","author":"Ying-Zheng","year":"2016","journal-title":"J. Control. Release"},{"key":"nanoae39e3bib19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202001410","type":"journal-article","article-title":"MT1-MMP-activated liposomes to improve tumor blood perfusion and drug delivery for enhanced pancreatic cancer therapy","volume":"7","author":"Yan","year":"2020","journal-title":"Adv. Sci."},{"key":"nanoae39e3bib20","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1080\/21655979.2021.2021347","type":"journal-article","article-title":"Cilengitide, an \u03b1v\u03b23-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model","volume":"13","author":"Xin","year":"2022","journal-title":"Bioengineered"},{"key":"nanoae39e3bib21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cellimm.2010.03.001","type":"journal-article","article-title":"Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice","volume":"263","author":"Pfannenstiel","year":"2010","journal-title":"Cell Immunol."},{"key":"nanoae39e3bib22","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1016\/j.biomaterials.2014.01.065","type":"journal-article","article-title":"A mannosylated cell-penetrating peptide-graft-polyethylenimine as a gene delivery vector","volume":"35","author":"Ying","year":"2014","journal-title":"Biomaterials"},{"key":"nanoae39e3bib23","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201700666","type":"journal-article","article-title":"Microneedle-assisted, DC-targeted codelivery of pTRP-2 and adjuvant of paclitaxel for transcutaneous immunotherapy","volume":"13","author":"Jiaojiao","year":"2017","journal-title":"Small"},{"key":"nanoae39e3bib24","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1039\/c4cc09603g","type":"journal-article","article-title":"Complementary hydrogen bonding interaction triggered co-assembly of an amphiphilic peptide and an anti-tumor drug","volume":"51","author":"Hong","year":"2015","journal-title":"Chem. Commun."},{"key":"nanoae39e3bib25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.blre.2018.11.002","type":"journal-article","article-title":"Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management","volume":"34","author":"Brudno","year":"2019","journal-title":"Blood Rev."},{"key":"nanoae39e3bib26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307030","type":"journal-article","article-title":"Allogeneic \u201cZombie Cell\u201d as off-the-shelf vaccine for postsurgical cancer immunotherapy","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"nanoae39e3bib27","doi-asserted-by":"publisher","first-page":"eaba4024","DOI":"10.1126\/sciadv.aba4024","type":"journal-article","article-title":"Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed","volume":"6","author":"Lei","year":"2020","journal-title":"Sci. Adv."},{"key":"nanoae39e3bib28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12951-021-01110-0","type":"journal-article","article-title":"Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery","volume":"19","author":"Wenyan","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"nanoae39e3bib29","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.19540\/j.cnki.cjcmm.20210409.301","type":"journal-article","article-title":"Optimization of formulation of paclitaxel nanosuspension encapsulated by erythrocyte membrane based on Box-Behnken method","volume":"47","author":"Fan","year":"2022","journal-title":"Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica"},{"key":"nanoae39e3bib30","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1039\/D4RA01026D","type":"journal-article","article-title":"Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform","volume":"14","author":"Qiuyan","year":"2024","journal-title":"RSC Adv."},{"key":"nanoae39e3bib31","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.2147\/ijn.s249144","type":"journal-article","article-title":"Co-delivery of paclitaxel and doxorubicin by pH-responsive prodrug micelles for cancer therapy","volume":"15","author":"Yanhua","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"nanoae39e3bib32","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1039\/C6TB01050D","type":"journal-article","article-title":"A pH-responsive nanocontainer based on hydrazone-bearing hollow silica nanoparticles for targeted tumor therapy","volume":"4","author":"Liangliang","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"nanoae39e3bib33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297749","type":"journal-article","article-title":"pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model","volume":"19","author":"Debasmita","year":"2024","journal-title":"PLoS One"},{"key":"nanoae39e3bib34","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202201159","type":"journal-article","article-title":"Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis","volume":"221","author":"Ebrahim","year":"2022","journal-title":"J. Cell Biol."},{"key":"nanoae39e3bib35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41571-020-0403-1","type":"journal-article","article-title":"TGF\u03b2 biology in cancer progression and immunotherapy","volume":"18","author":"Rik","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"nanoae39e3bib36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1287459","type":"journal-article","article-title":"Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target","volume":"15","author":"Conner","year":"2024","journal-title":"Front. Immunol."},{"key":"nanoae39e3bib37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12951-023-02078-9","type":"journal-article","article-title":"B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC","volume":"21","author":"Bing","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"nanoae39e3bib38","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.2147\/IJN.S461728","type":"journal-article","article-title":"Design and application of pH-responsive liposomes for site-specific delivery of cytotoxin from cobra venom","volume":"19","author":"Qing","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"nanoae39e3bib39","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201801899","type":"journal-article","article-title":"Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy","volume":"6","author":"Qingwei","year":"2019","journal-title":"Adv. Sci."},{"key":"nanoae39e3bib40","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2174\/187152010794728639","type":"journal-article","article-title":"Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation","volume":"10","author":"Carlos","year":"2011","journal-title":"Anticancer Agents Med. Chem."},{"key":"nanoae39e3bib41","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217536","type":"journal-article","article-title":"Targeting tumor microenvironment with RGD-functionalized nanoparticles for precision cancer therapy","volume":"614","author":"Sara","year":"2025","journal-title":"Cancer Lett."},{"key":"nanoae39e3bib42","doi-asserted-by":"publisher","first-page":"10748","DOI":"10.1039\/D1NR02065J","type":"journal-article","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Liwang","year":"2021","journal-title":"Nanoscale"},{"key":"nanoae39e3bib43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","type":"journal-article","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Xiaocong","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"nanoae39e3bib44","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3390\/pharmaceutics15051318","type":"journal-article","article-title":"Drug delivery strategies for the treatment of pancreatic cancer","volume":"15","author":"Oluwabukunmi","year":"2023","journal-title":"Pharmaceutics"},{"key":"nanoae39e3bib45","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1039\/D2CS01060G","type":"journal-article","article-title":"Stimuli-sensitive polymer prodrug nanocarriers by reversible-deactivation radical polymerization","volume":"53","author":"L\u00e9a","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"nanoae39e3bib46","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/eji.201343744","type":"journal-article","article-title":"Differential IL-10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction","volume":"44","author":"Haiyan","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"nanoae39e3bib47","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1111\/febs.13767","type":"journal-article","article-title":"Low doses of paclitaxel enhance liver metastasis of breast cancer cells in the mouse model","volume":"283","author":"Qi","year":"2016","journal-title":"FEBS J."},{"key":"nanoae39e3bib48","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1080\/03639045.2022.2045306","type":"journal-article","article-title":"The mechanisms of immune-chemotherapy with nanocomplex codelivery of pTRP-2 and adjuvant of paclitaxel against melanoma","volume":"47","author":"Zhonghua","year":"2022","journal-title":"Drug Dev. Ind. Pharm."},{"key":"nanoae39e3bib49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/biom13010179","type":"journal-article","article-title":"Multifunctional modified tumor cell membranes-coated adjuvant PTX against melanoma","volume":"13","author":"Zhonghua","year":"2023","journal-title":"Biomolecules"},{"key":"nanoae39e3bib50","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.biomaterials.2013.10.003","type":"journal-article","article-title":"Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response","volume":"35","author":"Thomas","year":"2014","journal-title":"Biomaterials"},{"key":"nanoae39e3bib51","doi-asserted-by":"publisher","first-page":"15864","DOI":"10.1021\/acsnano.4c02947","type":"journal-article","article-title":"Celecoxib augments paclitaxel-induced immunogenic cell death in triple-negative breast cancer","volume":"18","author":"Qian","year":"2024","journal-title":"ACS Nano"},{"key":"nanoae39e3bib52","doi-asserted-by":"publisher","first-page":"26690","DOI":"10.1021\/acsnano.4c06399","type":"journal-article","article-title":"Paclitaxel prodrug enables glutathione depletion to boost cancer treatment","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"nanoae39e3bib53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1241208","type":"journal-article","article-title":"It\u2019s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer","volume":"14","author":"Yao","year":"2023","journal-title":"Front. Immunol."},{"key":"nanoae39e3bib54","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1016\/j.vaccine.2010.04.046","type":"journal-article","article-title":"Paclitaxel acts as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice","volume":"28","author":"Yuan","year":"2010","journal-title":"Vaccine"},{"key":"nanoae39e3bib55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/1547691X.2012.655343","type":"journal-article","article-title":"Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice","volume":"9","author":"Sevko","year":"2012","journal-title":"J. Immunotoxicol."},{"key":"nanoae39e3bib56","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1084\/jem.20011097","type":"journal-article","article-title":"Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells","volume":"195","author":"Dhodapkar","year":"2002","journal-title":"J. Exp. Med."},{"key":"nanoae39e3bib57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41541-024-00869-1","type":"journal-article","article-title":"High production of IL-12 by human dendritic cells stimulated with combinations of pattern-recognition receptor agonists","volume":"9","author":"Brian","year":"2024","journal-title":"NPJ Vaccines"},{"key":"nanoae39e3bib58","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.3390\/ijms26073106","type":"journal-article","article-title":"The role and potential application of IL-12 in the immune regulation of tuberculosis","volume":"26","author":"Hangxing","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"nanoae39e3bib59","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1021\/acsnano.7b09041","type":"journal-article","article-title":"Cancer cell membrane-coated adjuvant nanoparticles with mannose modification for effective anticancer vaccination","volume":"12","author":"Rong","year":"2018","journal-title":"ACS Nano"},{"key":"nanoae39e3bib60","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301107","type":"journal-article","article-title":"Ultrasound responsive nanovaccine armed with engineered cancer cell membrane and RNA to prevent foreseeable metastasis","volume":"10","author":"Wenqi","year":"2023","journal-title":"Adv. Sci."},{"key":"nanoae39e3bib61","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41392-024-01859-4","type":"journal-article","article-title":"Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer","volume":"9","author":"Yun","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"nanoae39e3bib62","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","type":"journal-article","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Bagher","year":"2018","journal-title":"J. Cell Physiol."},{"key":"nanoae39e3bib63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.844142","type":"journal-article","article-title":"Immunotherapy: reshape the tumor immune microenvironment","volume":"13","author":"Bingzhe","year":"2022","journal-title":"Front. Immunol."},{"key":"nanoae39e3bib64","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1158\/2159-8290.CD-22-0876","type":"journal-article","article-title":"Context-specific determinants of the immunosuppressive tumor microenvironment in pancreatic cancer","volume":"13","author":"Chiara","year":"2023","journal-title":"Cancer Discov."},{"key":"nanoae39e3bib65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cmet.2023.12.019","type":"journal-article","article-title":"Niche-specific control of tissue function by regulatory T cells-Current challenges and perspectives for targeting metabolic disease","volume":"36","author":"Maike","year":"2024","journal-title":"Cell Metab."},{"key":"nanoae39e3bib66","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202401667","type":"journal-article","article-title":"Grooved microneedle patch augments adoptive T cell therapy against solid tumors via diverting regulatory T cells","volume":"36","author":"Ruyi","year":"2024","journal-title":"Adv. Mater."},{"key":"nanoae39e3bib67","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","type":"journal-article","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"New Engl. J. Med."},{"key":"nanoae39e3bib68","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1200\/JCO.2011.36.5742","type":"journal-article","article-title":"Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I\/II trial","volume":"29","author":"Von Hoff","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"nanoae39e3bib69","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1158\/2159-8290.CD-11-0242","type":"journal-article","article-title":"nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer","volume":"2","author":"Frese","year":"2012","journal-title":"Cancer Discov."}],"container-title":["Nanotechnology"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae39e3","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae39e3\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae39e3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae39e3\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae39e3\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae39e3\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae39e3\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae39e3\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:56:18Z","timestamp":1770198978000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae39e3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":69,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,2,4]]},"published-print":{"date-parts":[[2026,2,6]]}},"URL":"https:\/\/doi.org\/10.1088\/1361-6528\/ae39e3","relation":{},"ISSN":["0957-4484","1361-6528"],"issn-type":[{"value":"0957-4484","type":"print"},{"value":"1361-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"Construction and synergistic effect of a CGT-Cls-PTX\/CM nanocodelivery system targeting the tumor microenvironment","name":"article_title","label":"Article Title"},{"value":"Nanotechnology","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2026 The Author(s). Published by IOP Publishing Ltd","name":"copyright_information","label":"Copyright Information"},{"value":"2025-10-30","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2026-01-19","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2026-02-04","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}